Richmond Eye Associates, Richmond VA - Comprehensive Ophthalmology, Cataract, Glaucoma, Diabetes, Contact Lens - Home Page Donald W. Lumpkin, O.D. David M. Bowman, M.D. D. Alan Chandler, M.D. Bryan M. Brooks, M.D. Barry E. Roper, M.D. David W. MacMillan, M.D. Malcolm Magovern, M.D. Harold A. Bernstein, M.D.


Richmond Eye Associates
News
 

What's New at
Richmond Eye



Richmond Eye
in the News



Family Eye Health
Newsletter



Eye News Articles
   (Over 90 articles
   from 2000 to present)


Community
Involvement



Make an
Appointment



Richmond Eye Associates
                                  Eye News Articles


Articles about Eye Health and Disease from 2000 and earlier:

 

Artificial Solar Cell Retinal Implant Undergoing Clinical Trials in Retinitis Pigmentosa Patients

Optobionics Corporation has developed an artificial silicone retinal implant using solar cell technology that is undergoing clinical trials in humans, starting in June 2000. After 6 years of animal research, the FDA allowed the implants to be surgically placed beneath the retinas of 3 human volunteers to evaluate their biocompatibility, and potentially, their functionality. Dr. Alan Chow MD, an ophthalmologist, was interested in developing an implant that could electrically stimulate the retina to create some level vision for those patients with severe visual loss from retinitis pigmentosa (RP). In RP, the photoreceptor layer of the retina degenerates, leading to progressive visual loss. The condition often runs in families, and can lead to severe loss of vision in both eyes. There are hundreds of millions of photoreceptors in the retina which convert light impulses to electrical signals. The signals are carried by nerve tissue within the retina to the ganglion cell layer, which sends the visual signal to the brain through the optic nerve. In retinitis pigmentosa, the ganglion cell layer remains intact.

The artificial silicone retinal implant is 2mm in diameter, and is one-thousandth of an inch thick. There are thousands of solar cells on the surface of the the chip, which each generate a small electrical current in the presence of light. This current is transmitted to retina, as the chip is surgically placed beneath the retina.

At the Annual Meeting of the American Academy of Ophthalmology in October, 2000, it was reported that the implanted retinal chips were showing no signs of rejection, migration, or other complications. Information about any vision being stimulated by the chips has not been released at this time.

Retinal Implant is about 2 millimeters in diameter Retinal Implant shown under the retina of the macula near the optic nerve (structure to the right with vessels coming out from it) Surface of Retinal Implant showing thousands of solar cells

 


Return to the Eye News Index of Articles Page



Footer

At Richmond Eye Associates, "We Specialize in Family Eye Care"
Call 804-270-0330 for an Appointment
Toll Free 1-800-707-0330

Request an Appointment Online  |  Check Here Before Your Appointment | Locations
About Richmond Eye Associates | Specialties |  Insurances Accepted
Laser Vision Correction | Optical Shops  
Eye Disorder Section | Eye News Articles | Eye Health Issues | Special Interest Sections
Contact Richmond Eye Associates | Links | Interactive Sections
Career Opportunities | Public Service Programs | Clinical Section
Home Page | Terms of Use and Copyright
| Notice of Privacy Practices


David W. MacMillan, M.D.     Barry E. Roper, M.D.    D. Alan Chandler, M.D.    Malcolm Magovern, M.D.
Harold A. Bernstein, M.D.     David M. Bowman, M.D.     Bryan M. Brooks, M.D.     Donald W. Lumpkin, O.D.